insights_auto
Why is 544866 up 15.32%?
Dive Deeperchevron_right
544866:BOM
Molbio Diagnostics Limited
ā¹1,510.00
arrow_upward
+15.32%(+200.55) 1D
Oct 1, 3:30:00āÆPM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 544866...
Open
ā¹1,309.55
High
ā¹1,569.80
Low
ā¹1,309.45
Mkt. cap
173.94B
Avg. vol.
522.30K
Volume
1.34M
P/E ratio
102.20
52-wk high
ā¹1,686.50
52-wk low
ā¹925.80
EPS
ā¹14.77
No. of employees
1K
Open
ā¹1,309.55
High
ā¹1,569.80
Low
ā¹1,309.45
Mkt. cap
173.94B
Avg. vol.
522.30K
Volume
1.34M
P/E ratio
102.20
52-wk high
ā¹1,686.50
52-wk low
ā¹925.80
EPS
ā¹14.77
No. of employees
1K
News stories
From web sources and news partners
TradingView
·
15 hours ago
Molbio Diagnostics shares jump 5% as HDFC MF buys 1.99% stake via bulk deal | Newly listed stock up 71% from IPO price
Univest
·
15 hours ago
Molbio Diagnostics Share Price Target Rs 1,600: Stock Jumps 5% as HDFC Mutual Fund Buys 1.99% in Bulk Deal
scanx.trade
·
17 hours ago
India Business Excellence Fund III sells 2.06% stake in Molbio Diagnostics
Profile
Molbio Diagnostics Limited is an Indian medical diagnostics company headquartered in Verna, Goa, that develops molecular diagnostic technologies. Founded in 2000, the company developed the Truenat platform, a portable real-time PCR system used to diagnose infectious diseases including tuberculosis, HIV, and hepatitis.
The Truenat platform is recognized by the World Health Organization for the initial detection of tuberculosis and rifampicin resistance. Following clinical studies, including research published in The Lancet, the technology has been adopted by national health programs in over 85 countries.
In 2025, Molbio was awarded the Kochon Prize by the Stop TB Partnership, the world's largest award for tuberculosis. Wikipedia
About Molbio Diagnostics Limited